Literature DB >> 33054127

Detectable mutations precede late myeloid neoplasia in aplastic anemia.

Bhavisha A Patel1, Jack Ghannam1, Emma M Groarke1, Meghali Goswami1, Laura Dillon1, Fernanda Gutierrez-Rodrigues1, Olga Rios1, Diego Quinones Raffo1, Jennifer Lotter1, Neal S Young2, Christopher S Hourigan1.   

Abstract

Entities:  

Year:  2021        PMID： 33054127      PMCID： PMC7849750          DOI： 10.3324/haematol.2020.263046

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  How I treat acquired aplastic anemia.

Authors:  Phillip Scheinberg; Neal S Young
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

2.  Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.

Authors:  Yingmei Li; Xingxin Li; Meili Ge; Jun Shi; Linsheng Qian; Yizhou Zheng; Jianxiang Wang
Journal:  Ann Hematol       Date:  2011-01-05       Impact factor: 3.673

3.  Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia.

Authors:  Bogdan Dumitriu; Xingmin Feng; Danielle M Townsley; Yasutaka Ueda; Tetsuichi Yoshizato; Rodrigo T Calado; Yanqin Yang; Yoshiyuki Wakabayashi; Sachiko Kajigaya; Seishi Ogawa; Jun Zhu; Neal S Young
Journal:  Blood       Date:  2014-11-18       Impact factor: 22.113

Review 4.  Next-generation sequencing for measurable residual disease detection in acute myeloid leukaemia.

Authors:  Jack Ghannam; Laura W Dillon; Christopher S Hourigan
Journal:  Br J Haematol       Date:  2019-12-05       Impact factor: 6.998

5.  Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT).

Authors:  M M de Planque; A Bacigalupo; A Würsch; J M Hows; A Devergie; N Frickhofen; A Brand; C Nissen
Journal:  Br J Haematol       Date:  1989-09       Impact factor: 6.998

6.  Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.

Authors:  Samuel Quentin; Wendy Cuccuini; Raphael Ceccaldi; Olivier Nibourel; Corinne Pondarre; Marie-Pierre Pagès; Nadia Vasquez; Catherine Dubois d'Enghien; Jérôme Larghero; Régis Peffault de Latour; Vanderson Rocha; Jean-Hugues Dalle; Pascale Schneider; Mauricette Michallet; Gérard Michel; André Baruchel; François Sigaux; Eliane Gluckman; Thierry Leblanc; Dominique Stoppa-Lyonnet; Claude Preudhomme; Gérard Socié; Jean Soulier
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

7.  Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.

Authors:  Julia Skokowa; Doris Steinemann; Jenny E Katsman-Kuipers; Cornelia Zeidler; Olga Klimenkova; Maksim Klimiankou; Murat Unalan; Siarhei Kandabarau; Vahagn Makaryan; Renee Beekman; Kira Behrens; Carol Stocking; Julia Obenauer; Susanne Schnittger; Alexander Kohlmann; Marijke G Valkhof; Remco Hoogenboezem; Gudrun Göhring; Dirk Reinhardt; Brigitte Schlegelberger; Martin Stanulla; Peter Vandenberghe; Jean Donadieu; C Michel Zwaan; Ivo P Touw; Marry M van den Heuvel-Eibrink; David C Dale; Karl Welte
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

Review 8.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

9.  Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.

Authors:  Austin G Kulasekararaj; Jie Jiang; Alexander E Smith; Azim M Mohamedali; Syed Mian; Shreyans Gandhi; Joop Gaken; Barbara Czepulkowski; Judith C W Marsh; Ghulam J Mufti
Journal:  Blood       Date:  2014-08-18       Impact factor: 22.113

10.  Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Authors:  T Haferlach; Y Nagata; V Grossmann; Y Okuno; U Bacher; G Nagae; S Schnittger; M Sanada; A Kon; T Alpermann; K Yoshida; A Roller; N Nadarajah; Y Shiraishi; Y Shiozawa; K Chiba; H Tanaka; H P Koeffler; H-U Klein; M Dugas; H Aburatani; A Kohlmann; S Miyano; C Haferlach; W Kern; S Ogawa
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528
View more
  4 in total

1.  Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.

Authors:  Emma M Groarke; Bhavisha A Patel; Ruba Shalhoub; Fernanda Gutierrez-Rodrigues; Parth Desai; Harshraj Leuva; Yoshitaka Zaimoku; Casey Paton; Nina Spitofsky; Jennifer Lotter; Olga Rios; Richard W Childs; David J Young; Alina Dulau-Florea; Cynthia E Dunbar; Katherine R Calvo; Colin O Wu; Neal S Young
Journal:  Leukemia       Date:  2022-07-27       Impact factor: 12.883

2.  Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.

Authors:  Bhavisha A Patel; Emma M Groarke; Jennifer Lotter; Ruba Shalhoub; Fernanda Gutierrez-Rodrigues; Olga Rios; Diego Quinones Raffo; Colin O Wu; Neal S Young
Journal:  Blood       Date:  2022-01-06       Impact factor: 22.113

3.  HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.

Authors:  Yoshitaka Zaimoku; Bhavisha A Patel; Sharon D Adams; Ruba Shalhoub; Emma M Groarke; Audrey Ai Chin Lee; Sachiko Kajigaya; Xingmin Feng; Olga Julia Rios; Holly Eager; Lemlem Alemu; Diego Quinones Raffo; Colin O Wu; Willy A Flegel; Neal S Young
Journal:  Blood       Date:  2021-12-30       Impact factor: 25.476

Review 4.  Time to Move to the Single-Cell Level: Applications of Single-Cell Multi-Omics to Hematological Malignancies and Waldenström's Macroglobulinemia-A Particularly Heterogeneous Lymphoma.

Authors:  Ramón García-Sanz; Cristina Jiménez
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.